global tenecteplase drug market

Gaarti31 Mar, 2021Games

The report offers a brief analysis of the major regions in the Tenecteplase drug market, namely, Europe, Asia-Pacific, North America, Latin America, and the MEA. Among this, the North America Tenecteplase drug market was valued at US$ XX.15 Mn. in 2019 and is expected to reach a value of US$ XX.67 Mn. by 2027, with a CAGR of XX.36% during 2019-2027. This is attributed to the growing myocardial infection, innovations in clinical practice, and access to stroke treatment in the USA. According to the CDC, in Oct 2015, report 350,000 - 900,000 cases of VTE (Venous thromboembolism) are predicted every year in the United States. This impacts the Tenecteplase drug market growth in North America.